|
MED13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.764200E-03 |
| Normal-vs-Stage3 |
1.07590000020252E-07 |
| Normal-vs-Stage4 |
2.152500E-04 |
| Stage1-vs-Stage2 |
1.708010E-01 |
| Stage1-vs-Stage3 |
1.733990E-02 |
| Stage1-vs-Stage4 |
7.368400E-02 |
| Stage2-vs-Stage3 |
9.877600E-01 |
| Stage2-vs-Stage4 |
9.793200E-01 |
| Stage3-vs-Stage4 |
9.537000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
6.403800E-03 |
| Normal-vs-Asian |
1.9727599999908E-05 |
| Caucasian-vs-AfricanAmerican |
6.364200E-01 |
| Caucasian-vs-Asian |
6.576200E-01 |
| AfricanAmerican-vs-Asian |
8.368000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.09029998549704E-09 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.433800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62991842245219E-12 |
| Normal-vs-Age(41-60Yrs) |
8.42637071230001E-12 |
| Normal-vs-Age(61-80Yrs) |
1.315940E-03 |
| Normal-vs-Age(81-100Yrs) |
1.831670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.337780E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.043220E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.85360000000334E-05 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.151800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.704900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.749400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.124300E-03 |
| Classical-VS-Follicular |
2.12407869071285E-12 |
| Classical-VS-Other |
1.135030E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
4.058400E-03 |
| Tall-VS-Other |
1.871030E-01 |
| Tall-VS-Normal |
4.14440000000571E-05 |
| Follicular-VS-Other |
7.196000E-01 |
| Follicular-VS-Normal |
3.016000E-01 |
| Other-VS-Normal |
4.638400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.33159999377619E-09 |
| Normal-vs-N1 |
4.32959999999705E-05 |
| N0-vs-N1 |
3.602400E-01 |
|
|
